Current Report Filing (8-k)
May 13 2016 - 6:16AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of
1934
May 12, 2016
Date of Report (Date of earliest event reported)
AMGEN INC.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Delaware
|
|
000-37702
|
|
95-3540776
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer of
Identification Number)
|
|
|
|
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA
|
|
91320-1799
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
805-447-1000
(Registrants Telephone Number, Including Area Code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01. Other Events.
On May 12, 2016, Amgen Inc. (the Company) issued a press release announcing that it has commenced private offers to exchange certain outstanding debt securities of the Company for new
debt securities of the Company.
A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by
reference.
Item 9.01. Financial Statements and Exhibits.
|
|
|
Exhibit No.
|
|
Document Description
|
|
|
99.1
|
|
Press Release dated May 12, 2016.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AMGEN INC.
|
|
|
|
|
Date: May 12, 2016
|
|
|
|
By:
|
|
/s/ David W. Meline
|
|
|
|
|
Name:
|
|
David W. Meline
|
|
|
|
|
Title:
|
|
Executive Vice President and Chief Financial Officer
|
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Document Description
|
|
|
99.1
|
|
Press Release dated May 12, 2016.
|
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Sep 2023 to Sep 2024